felodipine has been researched along with Cancer of Mouth in 1 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yadalam, PK | 1 |
| Anegundi, RV | 1 |
| Ramadoss, R | 1 |
| Joseph, B | 1 |
| Veeramuthu, A | 1 |
1 other study available for felodipine and Cancer of Mouth
| Article | Year |
|---|---|
Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain.
Topics: Cancer Pain; Felodipine; Humans; Mouth Neoplasms; Pain; TRPV Cation Channels | 2022 |